Skip to main content

Table 1 Inclusion and exclusion criteria for study participants

From: The effectiveness and cost-effectiveness of 3- vs. 6-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART-refill groups in Zimbabwe: study protocol for a pragmatic, cluster-randomized trial

Inclusion criteria

Exclusion criteria

18 years of age or older

ART toxicity or tolerability issues in the prior 6 months

Confirmed HIV-1 infection based on the Zimbabwe national HIV-testing algorithm

Treatment for an opportunistic infection in the prior month

Received standard first-line ART for 6 months or longer

Receiving alternative first-line or second-line ART regimen

Viral load < 1000 copies/ml at enrollment

Active or suspected opportunistic infection

Weight ≥ 35 kg

Active or suspected tuberculosis

Willing to join a CARG

Comorbidities requiring more frequent visits to the facility than that required by the model of care

Provide informed consent for inclusion in the study

Confirmed pregnancy

 

Less than 18 months postpartum

  1. ART antiretroviral treatment, CARG community antiretroviral treatment-refill group, HIV human immunodeficiency virus